Published in Obesity and Diabetes Week, September 13th, 2004
While one study examines the beneficial role of hormones in women who experience early menopause, a second highlights the possible benefits of metformin in treating a prediabetes condition. A third study demonstrates that an insulin sensitizer could lessen the risk of diabetes for women with a common endocrine disorder.
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Obesity and Diabetes Week
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.